Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04093505
Title Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia) (GnG)
Acronym GnG
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors University Hospital Heidelberg
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University Hospital Heidelberg, Internal Medicine V Heidelberg Baden-Württemberg 69120 Germany Details
*Shaded cells indicate that there was no data available from for the field